The European markets have recently been navigating a complex landscape, balancing resilient economic data with geopolitical uncertainties. In this context, penny stocks—often smaller or newer companies—remain an intriguing investment area due to their potential for growth and affordability. While the term 'penny stock' might seem outdated, these stocks can still offer significant opportunities when underpinned by strong financials.
We're going to check out a few of the best picks from our screener tool.
IDL Diagnostics (OM:IDLDX)
Simply Wall St Financial Health Rating: ★★★★★★
Overview: IDL Diagnostics AB (publ) is a vitro diagnostics company based in Sweden that manufactures and sells IVD tests for oncological and bacterial diseases, with a market cap of SEK101.13 million.
Operations: The company generates its revenue primarily from two segments: Oncology, contributing SEK24.03 million, and Bacteriology, accounting for SEK30.43 million.
Market Cap: SEK101.13M
IDL Diagnostics AB, with a market cap of SEK101.13 million, operates in the vitro diagnostics space focusing on oncology and bacteriology, generating revenues of SEK24.03 million and SEK30.43 million respectively. Despite being unprofitable with a negative return on equity of -5.64%, the company has reduced losses over the past five years at a rate of 27.1% annually and remains debt-free for five years running. Its short-term assets comfortably cover both short- and long-term liabilities, while it maintains sufficient cash runway for over three years based on current free cash flow levels amidst high share price volatility.
- Click to explore a detailed breakdown of our findings in IDL Diagnostics' financial health report.
- Learn about IDL Diagnostics' historical performance here.
Safeture (OM:SFTR)
Simply Wall St Financial Health Rating: ★★★★★★
Overview: Safeture AB (publ) is a software as a service company providing solutions across Sweden, Europe, the Middle East and Africa, the United States, Asia, and Oceania with a market cap of SEK170.52 million.
Operations: There are no specific revenue segments reported for Safeture AB (publ).
Market Cap: SEK170.52M
Safeture AB, with a market cap of SEK170.52 million, has shown significant earnings growth of 96.4% over the past year and achieved profitability, contrasting its prior losses. The company is debt-free and maintains sufficient short-term assets (SEK46.1M) to cover liabilities (SEK35.8M). Recent earnings report highlights a net income of SEK0.848 million for Q2 2026 from revenue of SEK17.77 million, marking an improvement from the previous year's loss position. A new partnership with Aries Risk enhances its platform's appeal in Travel Risk Management, potentially supporting future revenue growth amidst stable weekly volatility at 7%.
- Navigate through the intricacies of Safeture with our comprehensive balance sheet health report here.
- Assess Safeture's future earnings estimates with our detailed growth reports.
M Food (WSE:MFD)
Simply Wall St Financial Health Rating: ★★★★★☆
Overview: M Food S.A. specializes in providing honey and bee products both in Poland and internationally, with a market cap of PLN33.99 million.
Operations: Revenue segments for M Food S.A. are not reported.
Market Cap: PLN33.99M
M Food S.A., with a market cap of PLN33.99 million, has shown impressive earnings growth of over 5000% in the past year, significantly outpacing the industry. Its net profit margin improved to 6.7%, up from 0.1% last year, indicating enhanced profitability. The company maintains a satisfactory net debt to equity ratio of 22.2%, with interest payments well covered by EBIT at an 8.4x multiple. Short-term assets (PLN67.8M) comfortably cover both short and long-term liabilities, though operating cash flow coverage for debt remains inadequate at 6.9%. Despite high earnings quality, share price volatility persists above average levels in Poland.
- Click here and access our complete financial health analysis report to understand the dynamics of M Food.
- Assess M Food's previous results with our detailed historical performance reports.
Taking Advantage
- Unlock more gems! Our European Penny Stocks screener has unearthed 299 more companies for you to explore.Click here to unveil our expertly curated list of 302 European Penny Stocks.
- Looking For Alternative Opportunities? Uncover 22 companies that survived and thrived after COVID and have the right ingredients to survive Trump's tariffs.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com